未登录

B

Bo Yan

Shanghai Jiaotong University School of Medicine

H指数:38

被引数:5,566

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The 5-year survival outcomes analysis of EGFR-TKI or/and chemotherapy as initial adjuvant therapy for completely resected IIIA non-small cell lung cancer

EGFR-TKI或/和化疗作为完全切除的IIIA期非小细胞肺癌初始辅助治疗的5年生存结局分析

IF4.4

2025-08-200

PRE

Integrated proteomics and N-glycoproteomic characterization of glioblastoma multiform revealed N-glycosylation heterogeneities as well as alterations in sialyation and fucosylation

整合蛋白质组学和N-糖蛋白质组学对胶质母细胞瘤多形性的表征，揭示了N-糖基化异质性以及唾液酸化和岩藻糖基化的改变

CLINICAL PROTEOMICS

IF3.3

2025-02-080

OA

Binding of carbon nanotube to BMP receptor 2 enhances cell differentiation and inhibits apoptosis via regulating bHLH transcription factors (vol 16, 33, 2025)

CELL DEATH & DISEASE

IF9.6

2025-01-210

OAAI

An oral, chemo-free regimen (osimertinib plus anlotinib) as first-line treatment for EGFR-mutated advanced NSCLC (AUTOMAN): Safety and survival outcome

一种口服、无化疗方案（osimertinib plus anlotinib）作为EGFR突变型晚期NSCLC的一线治疗（AUTOMAN研究）：安全性与生存结局

ANNALS OF ONCOLOGY

IF65.4

2024-12-010

PRE

Dietary emulsifier polysorbate 80 exposure accelerates age-related cognitive decline

膳食乳化剂聚山梨酯80暴露加速与年龄相关的认知下降

BRAIN BEHAVIOR AND IMMUNITY

IF7.6

2024-07-010

PRE

Augmented antitumor immune responses of HER2-targeted pyroptotic induction by long-lasting recombinant immunopyroptotins

IF3.6

2024-05-010

OAAI

Human-induced pluripotent stem cell-derived neural stem cell exosomes improve blood-brain barrier function after intracerebral hemorrhage by activating astrocytes via PI3K/AKT/MCP-1 axis

NEURAL REGENERATION RESEARCH

IF6.7

2024-04-160

OAAI

Machine learning-based risk models for procedural complications of radiofrequency ablation for atrial fibrillation

BMC MEDICAL INFORMATICS AND DECISION MAKING

IF3.8

2023-11-100

OAAI

Humanized single-domain antibody targeting HER2 enhances function of chimeric antigen receptor T cells

FRONTIERS IN IMMUNOLOGY

IF5.9

2023-11-072

OAAI

Effectiveness comparison of third-generation EGFR-TKI as initial and sequential therapy in adjuvant treatment for EGFR mutation-sensitive stage IIIA non-small cell lung cancer after surgery

第三代egfr-tki作为EGFR突变敏感的IIIA期非小细胞肺癌术后初始和序贯辅助治疗的疗效比较

IF3.6

2023-11-011

OAAI

Documenting a case of no remaining malignant cells after neoadjuvant therapy of colorectal cancer

ASIAN JOURNAL OF SURGERY

IF3.8

2023-11-010

OAAI

Neoadjuvant immunochemotherapy with pembrolizumab plus chemotherapy in resectable non-small cell lung cancer

新辅助免疫化疗联合pembrolizumab化疗治疗可切除非小细胞肺癌

IF3.6

2023-09-011

OAAI

Sirtuin 2 deficiency aggravates ageing-induced vascular remodelling in humans and mice

EUROPEAN HEART JOURNAL

IF35.6

2023-06-2828

OAAI

Glutamylation of an HIV-1 protein inhibits the immune response by hijacking STING

IF6.9

2023-05-016

OA

RETRACTION: TRIM25 blockade by RNA interference inhibited migration and invasion of gastric cancer cells through TGF-β signaling (Retraction of Vol 6, art no 19070, 2016)

SCIENTIFIC REPORTS

IF3.9

2023-04-050

OAAI

Microfibril-associated protein 2 is activated by POU class 2 homeobox 1 and promotes tumor growth and metastasis in tongue squamous cell carcinoma

IF3.1

2022-12-172

PRE

Discovery of a New Class of Uracil Derivatives as Potential Mixed Lineage Kinase Domain-like Protein (MLKL) Inhibitors

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2022-09-2213

PRE

Loss of MEG3 and upregulation of miR-145 play an important role in the invasion and migration of Cr(VI)-transformed cells

MEG3的丢失和miR-145的上调在Cr(VI) 转化细胞的侵袭和迁移中起重要作用

IF3.6

2022-08-015

OAAI

Onset of p53/NF-κB signaling crosstalk in human melanoma cells in response to anti-cancer theabrownin

IF4.2

2022-07-027

PRE

Multiple PDE3A modulators act as molecular glues promoting PDE3A-SLFN12 interaction and induce SLFN12 dephosphorylation and cell death

CELL CHEMICAL BIOLOGY

IF7.2

2022-06-0118

OAAI